IDEAYA Biosciences, Inc.
IDYANASDAQHealthcare● Active
$31.48
+$3.19(+11.28%)
Market Cap$2.8B
P/E Ratio—
52W High$39.28
52W Low$20.5
IDEAYA Biosciences, Inc. (IDYA) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · IDYA · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.11B) | ($0.27B) | ($0.11B) | ($0.06B) | ($0.05B) |
| Depreciation & Amort. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.00B | $0.03B | $0.02B | $0.01B | $0.01B |
| Change in Working Capital | $0.00B | $0.01B | ($0.01B) | ($0.04B) | ($0.02B) |
| Net Cash from Operations | ($0.07B) | ($0.25B) | ($0.12B) | ($0.09B) | ($0.06B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | ($0.61B) | ($1.19B) | ($0.60B) | ($0.26B) | ($0.31B) |
| Sales of Investments | $0.68B | $0.69B | $0.44B | $0.23B | $0.25B |
| Net Cash from Investing | $0.07B | ($0.50B) | ($0.16B) | ($0.03B) | ($0.07B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | $0.03B | $0.68B | $0.36B | $0.10B | $0.15B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.07B) | ($0.25B) | ($0.12B) | ($0.09B) | ($0.06B) |
| FCF Margin %(computed) | -33.59% | — | -502.85% | -177.92% | -209.09% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more IDEAYA Biosciences, Inc. data
About IDEAYA Biosciences, Inc. (IDYA) Cash Flow Statement
IDEAYA Biosciences, Inc. generated operating cash flow of ($0.07B) and free cash flow of ($0.07B) for 2025 — a FCF margin of -33.59%. Capital expenditure was ($0.00B).
Frequently asked questions
IDYA · 4 questionsIDEAYA Biosciences, Inc. generated free cash flow of ($0.07B) for 2025, up 70.8% year-over-year.
IDYA free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10